跳至主要内容
临床试验/EUCTR2018-003640-23-IT
EUCTR2018-003640-23-IT进行中(未招募)1 期

SE OF HEPATITIS C+ DONORS FOR SOLID ORGAN TRANSPLANTATION IN A GEOGRAPHICAL AREA WITH HCV+ ENDEMIC INFECTION AND WITH A LOW-RATE CADAVERIC ORGAN DONOR AVAILABILITY.A PHASE II OPEN, MONOCENTRIC CLINICAL STUDY. - DONORHEPAC

ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT0 个研究点目标入组 212 人开始时间: 2021年1月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
212

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1) male or female recipient over 18 years of age.
  • 2) negative candidate for HCV candidate and inserted in waiting list for solid organ transplant at IRCCS / ISMETT.
  • 3) Female recipients potentially able to undertake a pregnancy who have committed themselves to ensure an effective practice of birth control during the first 6 months of study.
  • 4) recipient affected by a terminal stage disease or oncological pathology, suitable candidate and included in waiting list for organ transplantation at IRCCS / ISMETT.
  • 5) a patient who understands the purpose and risks of the study, who has been fully informed and has given written informed consent.
  • 6) a patient unable to write and / or read, but who is fully capable of understanding the oral information proposed by the researcher (or the appointed representative) and who has given oral informed consent written in written form by an independent third person .
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 170
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 42

排除标准

  • 1) patients with acute organ failure
  • 2) pediatric patients or pediatric donor solid organ transplant candidates
  • 3) patient in poor multi-organ clinical conditions
  • 4) patient candidate for multi-organ transplantation
  • 5) participant or who has participated in another clinical trial and / or who is taking or has taken an experimental drug in the last 30 days
  • 6) patient with absolute improbability to respect the programmatic visits foreseen by the protocol
  • 7) patient with any form of substance abuse, and / or carrier of psychiatric disorders or a condition that, in the opinion of the investigator, can invalidate the communication with the researcher himself.
  • 8) patient over the age of 70.

研究者

发起方
ISTITUTO MEDITERRANEO PER I TRAPIANTI E TERAPIE AD ALTA SPECIALIZZAZIONE - ISMETT

相似试验